Aekyung Industrial Co., Ltd. Overview
Aekyung Industrial is a mid-sized Korean "life-beauty" consumer-goods company. It combines a mass household and personal-care franchise with a smaller, more volatile cosmetics business. Its household brands include 2080, Kerasys, Spark, Trio, Shower Mate, Luvscent, Labsin and Liq. The cosmetics business is anchored by AGE20's and LUNA, plus the newer signiq and ONE THING skincare lines. Household goods supply roughly two-thirds of revenue and most of the stable cash generation. Cosmetics has historically supplied most of the profit upside, with heavy dependence on China.
After a weak FY2025 (revenue −3.6%, operating profit −54.8%), Taekwang Industrial acquired the company in March 2026 as its entry point into K-beauty. The new owner has stated a target of raising cosmetics to at least 50% of revenue by 2028, up from about 32% in FY2025. Management is pursuing a revenue-first strategy: rebalancing away from China toward the US, Japan and Europe, and spending heavily on marketing. As a result, margins sit near breakeven and the investment case depends largely on execution.
What the company does
Aekyung Industrial develops, manufactures, markets and distributes two broad product families.
Household goods (생활용품): personal care (hair care, body care, oral care), fabric care (powder and liquid laundry detergents, fabric softeners, neutral detergents), kitchen care (dishwashing detergents), hygiene products and home-care items.
Cosmetics (화장품): base makeup (cushion and "essence cover pact" compacts), colour cosmetics, cleansing products and, increasingly, skincare.
The company's FY2021 business report describes it as two operating segments. The cosmetics segment runs basic and colour cosmetics centred on AGE20's and LUNA. The household goods segment covers detergents, soaps, quasi-drugs (including toothpaste) and personal-care items [S39]. Its registered business purposes also include cosmetics manufacturing, wholesale/retail and import/export of chemical products, household goods, beverages, food and general merchandise [S39].
Business and revenue model
Revenue model: Almost entirely product sales (B2C brands sold through B2B retail channels and the company's own and third-party e-commerce). There is no material subscription, service or licensing income in the sources reviewed. A small "other" line appears in segment reporting: about KRW 11 bn in FY2025 (derived) [S5].
Manufacturing model: Hybrid. The company runs its own plants. Its Daejeon plant held powder-detergent capacity of 82,725 tonnes in the FY2021 business report [S39]. It also uses OEM/ODM suppliers. This includes Chinese contract manufacturer Domy (Zhongshan) Chemical, which made six imported 2080 toothpaste SKUs recalled in January 2026 [S21][S22].
Value-chain position: Branded consumer-goods owner. It sits between raw-material and packaging suppliers (and contract manufacturers) and retail channels: hypermarkets, convenience stores, H&B stores such as Olive Young, Daiso, TV home shopping, duty-free, e-commerce marketplaces (Coupang, Naver, Amazon, Tmall, Douyin, TikTok Shop, Qoo10) and overseas distributors.
Customer types: Mass-market consumers reached through domestic retailers, home shopping, H&B chains and online platforms. Overseas buyers include distributors and retailers such as Walmart (US), Olive Young USA, Rossmann (Poland) and Matsumoto Kiyoshi (Japan) [S13][S14][S35].
End-markets: Korean household and personal care (mature, low growth); Chinese masstige cosmetics (historically the largest export market); and Japanese, US, European, Russian/CIS and Central Asian personal care and cosmetics (current growth vectors) [S5][S14].
Company self-description versus independent characterisation
Company framing: Before 2026 the company described itself as a "life-beauty company" (생활뷰티기업) [S12]. Since joining the Taekwang group it calls itself a "global total beauty company" (글로벌 토탈 뷰티 기업). It has stated an ambition to become a leading total-beauty company representing K-beauty [S19][S20]. Its stated operating strategy has four pillars [S11][S13]:
-
premium-based profitability
-
globalisation
-
responsiveness to growth channel platforms
-
brand-portfolio diversification
Independent characterisation:
Profit structure is inverted relative to the revenue mix: Household goods are about 65% of revenue but earn low single-digit margins. Cosmetics earned double-digit margins in good years (14.5% in FY2023, derived) but collapsed to 3.4% in FY2025 [S5].
- Cosmetics has long been a single-brand, single-product, single-market business. It has relied on AGE20's Essence Cover Pact and on China. At IPO, more than 85% of cosmetics revenue came from AGE20's [S38]. In 2019 the brand was reported at about 90% of segment results [S50]. China still accounts for more than 80% of overseas revenue as of October 2026 [S5].
The company is now in a deliberate investment phase: Under new ownership, Hana Securities notes that marketing is being raised across every region and category simultaneously. It also notes that mix is shifting toward low-margin household goods. Together these compress margins in the near term [S5].
Strategy
Stated strategy
Pre-acquisition (2024–2025): The company's stated priorities were [S11][S13]:
-
premium-based profitability
-
globalisation
-
responsiveness to growth channels and platforms
-
brand-portfolio diversification (added in 2026)
Management also said it would keep investing domestically and abroad, and launch global-exclusive cosmetics and household products [S9].
Post-acquisition vision (March 2026 AGM) [S18][S19][S20]:
Beauty mix: Raise cosmetics to at least 50% of revenue by 2028, from about 32% in FY2025.
Skincare pivot: Re-weight the portfolio from colour cosmetics toward skincare, led by signiq and ONE THING, while running AGE20's and LUNA as a parallel makeup track.
Household efficiency: Focus household goods (about 60% of revenue) on upgrading hero brands such as Kerasys and Shower Mate.
"Country rebalancing": Reduce China dependence and expand in the US and Europe.
Organisation: Split the business into Makeup, Skincare, Personal Beauty and Home/Dental Care, and create a digital-marketing organisation.
Synergies: Explore cooperation with Taekwang's data home-shopping channel, Shopping NT.
Mega-brands: Grow Kerasys, Shower Mate and Luvscent into global mega-brands and expand global retail distribution [S13].
Acquirer's stated rationale: Taekwang Industrial CEO Yoo Tae-ho told shareholders the deal was not a pure financial investment. He described it as a starting point for entering K-beauty and a base for business expansion through continued investment [S49]. Taekwang has said it plans to invest trillions of won across cosmetics, energy and real-estate development [S32].
Initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Detail | Source |
|---|---|---|---|
| AGE20's US launch with Silicon2 | Apr 2024 onward | Amazon US and Silicon2's MOIDA store; US-tailored shades; sun-care launch | [S36] |
| China MCN partnership (Xinxuan Group) | Mar 2025 | Live-commerce push in China | [S31] |
| Daiso and Olive Young channel expansion | 2,025 | Two Edit launch for Daiso; new SKUs across H&B channels | [S10][S43] |
| signiq global skincare brand | Sep 2025 | Amazon US, later TikTok Shop, Tmall and Douyin | [S37][S13] |
| Luvscent and Shower Mate at Walmart US; Kerasys at Walmart | 2025–Mar 2026 | Kerasys: about 390 stores in 35 states plus online | [S35] |
| Local-sourcing partnership with Ottogi | Jan 2026 | Cooperation on regional production base and raw-material use (details not disclosed) | [S58] |
| Absorption of ONE THING | Apr–Jun 2026 | Skincare division created; brand rebuilt around the centella line | [S24][S25] |
| New channels in Poland and Japan | Q1 2026 | Rossmann (Poland), Matsumoto Kiyoshi (Japan) | [S13] |
| Olive Young USA listing | Q2 2026 | AGE20's and LUNA | [S14] |
| K-pop marketing in Brazil, Kazakhstan, Uzbekistan | 2,026 | Consumer-awareness campaigns | [S14][S60] |
| Trade shows (e.g. Cosmoprof Las Vegas 2026) | 2025–2026 | AGE20's ranked first in makeup at Cosmoprof 2025 | [S11b][S14] |
| Labour agreement | Jun 2026 | 2026 wage deal signed without dispute; HQ and corporate name retained | [S34] |
ESG and sustainability commitments
Sustainability reports have been published since 2022, covering FY2021 onward [S39b]. A mono-material packaging collaboration with SK Geo Centric was reported [S60b]. No quantified emissions targets were found.
Cost programmes
No formal cost programme with targets was disclosed. Management's posture is the opposite: marketing intensity is being raised.
Medium-term financial targets and guidance
Explicit target: cosmetics ≥50% of revenue by 2028 [S19].
Q4 2026 internal goal: quarterly revenue of KRW 200 bn in the peak season [S5].
2027 intent: pursue revenue growth and margin improvement together [S5].
- No formal revenue or EPS guidance has been published.
Historical precedent: The 2018 IPO targets of KRW 1 trillion revenue and a 15% operating margin by 2020 were missed by a wide margin. FY2020 revenue was KRW 588.1 bn with a 3.8% operating margin [S38][S50].
Products & Services
Pricing models are not publicly disclosed for any brand; all products are sold at retail list prices through channels.
Cosmetics segment
| Brand | Description and positioning | Flagship / recent products | Target customer | Launch / latest | Source |
|---|---|---|---|---|---|
| AGE20's (에이지투웨니스) | Core base-makeup brand built on the "Essence Cover Pact". The company says its "Essence Pocket" technology holds about 71% moisture essence inside a solid foundation. US shade range expanded from 6 to 11. About 53 SKUs in 2026. | Signature Essence Cover Pact; Signature Master Advanced Essence Pact; Velvet Lasting Pact; Super Ectoin Prime Foundation Pact (2025); MelaDefense spot sun care (2026) | Women in their 20s–40s; China (Tmall/Douyin/TikTok live), Korea home shopping and H&B, Japan (Qoo10), US (Amazon, Olive Young USA), Poland (2026) | Launched 2012; new SKUs annually | [S38][S9][S12][S14][S59][S60] |
| LUNA (루나) | Makeup-specialist colour brand; Japan is the lead overseas market. About 23 SKUs. Expanding into Russia, the UK and the US. | Long Lasting Tip Concealer; Glassy Layer Tint; Lip & Cheek (2026) | Women in their 20s–30s; Japan variety and drug stores, Qoo10, Amazon US, Olive Young USA | 2026 SKUs added | [S9][S12][S14][S60] |
| POINT (포인트) | Cleansing-specialist brand | Mascara Cleanser; Pack Cleanser (2026) | Mass H&B / Daiso shoppers | Listed among cosmetics brands at IPO (2018); 2026 launches | [S38][S14] |
| signiq (시그닉) | The company's first skincare brand designed for global (US) consumers. "Skin signal care" concept; name combines "signal" and "clinic". | Plumping Peptide line (4 products, with ginger peptide and deep-liposome technology); 3 eye creams (2026) | US consumers aged 25–35; also Amazon US, TikTok Shop, Tmall, Douyin | Sep 2025 | [S37][S13][S14][S52] |
| ONE THING (원씽) | Minimalist, single-key-ingredient skincare; acquired in 2022 and absorbed in June 2026. Being repositioned as a global minimalist skincare brand around its centella (병풀) line. FY2025 standalone revenue about KRW 7.2 bn with a net loss of about KRW 3.0 bn. | Centella line (cleansers, creams); Jojoba Deep Moisture Cream | Global skincare consumers | Acquired May 2022; merged Jun 2026 | [S24][S25][S14] |
| Two Edit (투에딧) | Daiso-channel cosmetics brand | — | Value-channel consumers | 2,025 | [S43] |
| Legacy / discontinued | Bonkyeol (본결, launched around 2020); Flow (2018 basic skincare); Sosopul (2019, withdrawn early) | — | — | — | [S50][S56b] |
Household goods segment
| Category | Brands (as disclosed) | Notes | Source |
|---|---|---|---|
| Hair care | Kerasys (케라시스); Salon de Magie (살롱드마지); Dongui Hongsam (동의홍삼) | Kerasys is the premium hair-care flagship. The Propolis Hair Bonding / Pro-Repair line for heavily damaged hair (shampoo, treatment conditioner, leave-in spray) entered Walmart US in March 2026. Tmall flagship opened in 2020. K-pop marketing in Kazakhstan and Uzbekistan. | [S35][S14][S50][S39] |
| Body care | Shower Mate (샤워메이트); Luvscent (럽센트); Black Fore (블랙포레); Bicolor (바이컬러); Vaseline (listed in the company's brand portfolio; licensing basis not disclosed) | Shower Mate and Luvscent are listed at Walmart US. Luvscent entered Japan in 2025. Black Fore and Bicolor are described as premium growth brands. | [S35][S10][S12][S39] |
| Oral care | 2080 (toothpaste, toothbrushes) | Long-standing domestic flagship. Six China-made SKUs were recalled in January 2026: Basic, Daily Care, Smart Care Plus, Classic Care, Triple Effect Alpha Fresh and Triple Effect Alpha Strong. Domestically made 2080 products tested clean. | [S21][S22] |
| Fabric care | Spark (스파크, powder detergent); Liq (리큐, gel detergent); Wool Shampoo (울샴푸, neutral detergent); Le Chatelat (르샤트라, fabric softener) | Fabric-softener launches drove household growth in 2019. | [S38][S39][S50] |
| Kitchen care | Trio (트리오); Soonsaem (순샘) | Trio is described by the company as Korea's first dishwashing detergent. | [S39][S38] |
| Hygiene and home care | Labsin (랩신); Home Vaccine (홈백신); and other home-care marks | Labsin was launched in Q4 2019 and scaled during COVID. | [S50][S39] |
| Other marks in the portfolio | Derma & More, Alpist, Chiubi, Salarium, Smalland, Sabor, Herb Mari 1848, Mom's Choice (엄마의선택), Petitee (쁘띠에) | Individual revenue not disclosed. | [S39] |
Brand-level revenue is not publicly disclosed. The only data points available are historical: AGE20's at more than 85% of cosmetics revenue at IPO [S38], and AGE20's at about 90% of cosmetics results in 2019 [S50].
Financial Narrative
All figures are K-IFRS consolidated, KRW, fiscal years ending 31 December. Primary data comes from S&P Global Market Intelligence via StockAnalysis [S1][S2][S3], cross-checked against Hana Securities [S5] and finanzen.at [S6].
Income statement
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Cosmetics revenue (KRW Bn) | 251.2 | 261.5 | 214.9 |
Household goods revenue (KRW Bn) | 418.0 | 417.6 | 428.5 |
Other and eliminations (KRW Bn, derived) | -0.3 | 0.0 | 11.1 |
Consolidated revenue (KRW Bn) | 668.9 | 679.1 | 654.5 |
Cosmetics operating profit (KRW Bn) | 36.4 | 29.1 | 7.4 |
Household goods operating profit (KRW Bn) | 25.6 | 18.3 | 13.7 |
Cosmetics operating margin (%) | 14.5 | 11.1 | 3.4 |
Household goods operating margin (%) | 6.1 | 4.4 | 3.2 |
Cosmetics share of consolidated revenue (%) | 37.6 | 38.5 | 32.8 |
Household share of consolidated revenue (%) | 62.5 | 61.5 | 65.5 |
Segment Revenue
| Metric | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|
Consolidated revenue (KRW Bn) | 151.1 | 171.3 | 169.3 | 162.9 | 158.8 | 194.2 |
Cosmetics revenue (KRW Bn) | 45.9 | 62.5 | 51.5 | 55.0 | 51.9 | 75.3 |
Cosmetics – domestic (KRW Bn) | 22.0 | 21.9 | 19.1 | 23.1 | 19.7 | 21.1 |
Cosmetics – overseas (KRW Bn) | 23.9 | 40.6 | 32.4 | 31.9 | 32.2 | 54.2 |
Household revenue (KRW Bn) | 104.0 | 105.1 | 114.6 | 104.8 | 103.7 | 115.2 |
Consolidated operating profit (KRW Bn) | 6.0 | 11.2 | 7.3 | -3.4 | -1.6 | 4.5 |
Cosmetics operating profit (KRW Bn) | 1.1 | 6.8 | 2.1 | -2.6 | -1.5 | 4.1 |
Household operating profit (KRW Bn) | 4.9 | 4.1 | 5.4 | -0.7 | 0.2 | 0.4 |
Revenue by Segment
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cosmetics gross segment revenue (KRW Bn) | 248.3 | 261.1 | 313.7 | 327.3 | 254.0 |
Household gross segment revenue (KRW Bn) | 355.5 | 392.7 | 418.2 | 420.6 | 441.7 |
Other (KRW Bn) | 11.6 | 15.9 | 15.8 | 15.4 | 28.6 |
Consolidation adjustment (KRW Bn) | -41.4 | -59.3 | -78.8 | -84.3 | -69.8 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 573.9 | 610.4 | 668.9 | 679.1 | 654.5 |
Revenue growth (%) | -2.4 | 6.4 | 9.6 | 1.5 | -3.6 |
Gross profit (KRW Bn) | 242.7 | 268.4 | 314.7 | 315.5 | 287.2 |
SG&A (KRW Bn) | 218 | 229 | 253 | 269 | 266 |
Operating income (KRW Bn) | 24.4 | 39.0 | 61.9 | 46.8 | 21.1 |
D&A (KRW Bn) | 15.2 | 15.2 | 15.2 | 16.1 | 17.3 |
EBITDA = OI + D&A (KRW Bn, derived) | 39.6 | 54.2 | 77.2 | 63.0 | 38.4 |
Pre-tax income (KRW Bn, derived from pre-tax margin) | 20.4 | 22.8 | 59.4 | 55.8 | 19.6 |
Net income (KRW Bn) | 15.7 | 16.6 | 48.8 | 42.6 | 15.2 |
EPS basic (KRW) | 579.56 | 631.70 | 1,896.85 | 1,689.41 | 603.56 |
EPS diluted (KRW) | 579.56 | 631.70 | 1,893.50 | 1,689.41 | 603.56 |
Dividend per share (KRW) | 200 | 310 | 580 | 580 | 200 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 42.3 | 44.0 | 47.1 | 46.5 | 43.9 |
Operating margin (%) | 4.3 | 6.4 | 9.3 | 6.9 | 3.2 |
EBITDA margin (%, derived) | 6.9 | 8.9 | 11.5 | 9.3 | 5.9 |
Pre-tax margin (%) | 3.6 | 3.7 | 8.9 | 8.2 | 3.0 |
Net margin (%) | 2.7 | 2.7 | 7.3 | 6.3 | 2.3 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (KRW Bn) | 431.5 | 482.6 | 482.4 | 499.4 | 497.8 |
Cash & equivalents (KRW Bn) | 106.1 | 120.4 | 65.2 | 23.3 | 61.4 |
Cash + short-term investments (KRW Bn) | 121.8 | 140.4 | 115.6 | 55.9 | 68.8 |
Accounts receivable (KRW Bn) | 48.0 | 51.2 | 63.7 | 71.7 | 57.1 |
Inventory (KRW Bn) | 80.0 | 79.0 | 78.1 | 93.7 | 104.4 |
Short-term debt incl. current leases (KRW Bn, derived) | 2.07 | 24.03 | 1.48 | 3.05 | 7.14 |
Long-term debt incl. leases (KRW Bn, derived) | 1.43 | 1.04 | 1.03 | 0.99 | 0.49 |
Total debt (KRW Bn) | 3.50 | 25.07 | 2.51 | 4.04 | 7.63 |
Net debt (KRW Bn; negative = net cash) | -118.3 | -115.3 | -113.1 | -51.9 | -61.2 |
Total equity (KRW Bn) | 346.2 | 359.0 | 387.6 | 400.6 | 399.1 |
Goodwill (KRW Bn) | 0.18 | 10.06 | 6.01 | 6.01 | 3.16 |
Other intangibles (KRW Bn) | 6.16 | 7.49 | 7.48 | 6.21 | 4.74 |
Goodwill + intangibles (KRW Bn) | 6.34 | 17.55 | 13.49 | 12.21 | 7.90 |
Working capital (KRW Bn) | 186.9 | 158.6 | 173.1 | 196.5 | 193.9 |
Book value per share (KRW) | 13,210 | 13,672 | 15,063 | 15,894 | 15,841 |
Cash Flow and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (KRW Bn) | 48.3 | 33.9 | 50.6 | 24.8 | 41.0 |
Capital expenditure (KRW Bn) | -17.7 | -22.2 | -31.1 | -12.3 | -7.9 |
Free cash flow (KRW Bn) | 30.6 | 11.7 | 19.5 | 12.5 | 33.1 |
FCF margin (%) | 5.3 | 1.9 | 2.9 | 1.8 | 5.1 |
Dividends paid (KRW Bn) | -5.24 | -5.24 | -8.13 | -14.91 | -14.61 |
Share buybacks (KRW Bn) | 0 | 0 | -10.01 | -10.04 | 0 |
Cash acquisitions (KRW Bn) | 0 | -10.85 | 0 | 0 | -10.34 |
Change in working capital (KRW Bn) | 2.4 | -22.6 | -20.5 | -41.6 | 0.4 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 4.5 | 4.6 | 12.6 | 10.6 | 3.8 |
ROA (%) | 3.6 | 3.4 | 10.1 | 8.5 | 3.1 |
ROIC (%) | 8.3 | 11.9 | 21.0 | 13.7 | 6.0 |
Current ratio (x, derived) | 3.49 | 2.36 | 2.91 | 3.08 | 3.12 |
Total debt / equity (x, derived) | 0.010 | 0.070 | 0.006 | 0.010 | 0.019 |
Total liabilities / equity (%) | 24.6 | 34.4 | 24.4 | 24.6 | 24.7 |
Net debt / EBITDA (x, derived; negative = net cash) | -2.99 | -2.13 | -1.47 | -0.82 | -1.59 |
Interest coverage (x) | 65.4 | 145.7 | 100.5 | 143.9 | 51.0 |
Asset turnover (x, derived) | 1.33 | 1.34 | 1.39 | 1.38 | 1.31 |
Days sales outstanding (days, derived) | 30.5 | 30.6 | 34.8 | 38.5 | 31.8 |
Days inventory outstanding (days, derived) | 88.2 | 84.3 | 80.5 | 94.1 | 103.7 |
Days payables outstanding (days, derived) | 48.0 | 43.1 | 44.2 | 43.1 | 49.5 |
Cash conversion cycle (days, derived) | 70.7 | 71.8 | 71.1 | 89.5 | 86.0 |
Revenue by Region and Revenue by Region (%)
| Metric | FY2024 | FY2025 |
|---|---|---|
Cosmetics domestic revenue (KRW Bn) | 87.8 | 86.1 |
Cosmetics overseas revenue (KRW Bn) | 173.7 | 128.8 |
Overseas share of cosmetics (%) | 66.4 | 59.9 |
Revenue by Region and Revenue by Region (%) (FY2025)
| Metric | FY2025 |
|---|---|
Domestic revenue (KRW Bn) | 446.9 |
Export / overseas revenue (KRW Bn) | 207.6 |
Overseas share (%) | 31.7 |
Per-Share Data and Valuation Multiples (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Implied year-end share price (KRW, = P/E × EPS per Hana; derived) | 18,981 | 20,879 | 18,645 | 13,218 | 13,133 |
P/E (x, year-end) | 31.9 | 33.3 | 10.1 | 8.2 | 22.8 |
P/B (x) | 1.4 | 1.5 | 1.2 | 0.8 | 0.8 |
EV/EBITDA (x) | 9.7 | 8.1 | 4.9 | 3.9 | 6.1 |
Dividend yield (%) | 1.16 | 1.62 | 3.29 | 4.63 | 1.54 |
Capital Markets
| Metric | Aekyung Industrial | Basis / date |
|---|---|---|
P/E (trailing) | 16.1x | 28 Sep 2026 |
P/B | 0.71–0.75x | Jul–Sep 2026 |
EV/EBITDA | 5.4x | Jul 2026 |
EV/Sales | 0.25x | Jul 2026 |
Enterprise value | about KRW 167 bn (market cap minus net cash) | Jul 2026 |
Peer — Amorepacific Corp. | 2026E P/E 27.9x; EV/Sales 2026E 2.08x | Feb 2026 |
Peer — small/mid K-beauty | 12-month forward P/E about 5.8–11.4x | Sep 2026 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
DPS (KRW) | 200 | 310 | 580 | 580 | 200 |
Total dividend (KRW Bn) | 5.24 | 5.24 | 8.13 | 14.91 | 14.61 |
Payout ratio on EPS (%, derived) | 34.5 | 49.1 | 30.6 | 34.3 | 33.1 |
Analyst Conclusions
Management guidance and broker expectations
Management: - Cosmetics ≥50% of revenue by 2028 [S19].
-
Q4 2026 peak-season revenue goal of KRW 200 bn [S5].
-
2027 to combine growth with margin recovery [S5].
Hana (sole published model): - Q3 2026E revenue KRW 186.2 bn (+10%) with an operating loss of KRW 0.6 bn, due to higher overseas household-promotion costs.
-
Q4 2026E revenue KRW 198.2 bn with operating profit of KRW 5.1 bn.
-
FY2026E revenue KRW 737.4 bn (+12.7%), operating profit KRW 7.4 bn (OPM 1.0%), net income KRW 20.3 bn.
-
FY2027E revenue KRW 781.7 bn, operating profit KRW 21.4 bn (OPM 2.7%) [S5].
Consensus: not available [S5].
Bull case
-
Overseas inflection is real. Overseas cosmetics grew 34.8% and 33.5% in Q1 and Q2 2026, and the overseas share of revenue reached 42% [S5][S14]. If US channels (Walmart, Olive Young USA, Amazon, TikTok Shop) scale, operating leverage on a gross margin of about 44% [S1] could restore high-single-digit margins.
-
Balance-sheet optionality. Net cash of KRW 117.5 bn [S2] against a market cap of about KRW 296 bn [S5] means roughly 40% of the market value is cash. EV/EBITDA is about 5x [S4].
-
Strategic sponsor. Taekwang paid about KRW 26,800 per share after the price adjustment (derived: 447.5 bn / 16.67 m shares) [S17] and has stated a long-horizon commitment [S49]. This supports continued investment and possible further capital deployment.
Bear case
-
Profits may not return. Hana's FY2026 operating profit estimate of KRW 7.4 bn is a fraction of FY2023's KRW 61.9 bn. Marketing is rising everywhere at once and the cost ratio is drifting upward [S5].
-
Brand-trust damage. The 2080 recall exposed both supplier-control and disclosure failures (12-day late recall plan) [S22][S23], with sanctions pending [S22]. Household goods are the profit backstop, so erosion there would hurt.
-
Minority-shareholder misalignment. The free float is small and coverage is thin [S4][S5]. The controller acquired at a large premium without a tender offer. Capital allocation may prioritise group objectives over minority returns.
Key catalysts and monitorables (next 12 months)
-
Q3 2026 results (expected November 2026): whether overseas growth holds at +10% or better and the operating loss stays contained [S5].
-
Q4 2026 peak-season revenue against the KRW 200 bn goal [S5].
-
MFDS administrative-sanction decision on 2080, and any prosecution referral [S22].
-
Humidifier-disinfectant remand verdict and the KFTC referral outcome [S28][S29].
-
US channel expansion: number of Walmart doors, Olive Young USA sell-through and signiq traction on Amazon/TikTok [S14][S35].
-
Inventory trajectory (KRW 121.9 bn at June 2026) and working-capital release [S2].
-
Any Taekwang-led capital actions (capital injection, M&A, dividend policy) and progress on Shopping NT synergies [S19].
-
FY2026 DPS decision (early 2027).
Analyst verdict
Aekyung Industrial is now a turnaround-plus-repositioning story owned by a non-specialist strategic buyer. FY2025 marked a cyclical and structural low. Revenue fell to KRW 654.5 bn and operating profit to KRW 21.1 bn. Cosmetics margins collapsed from 14.5% to 3.4% as the China-dependent AGE20's franchise faltered. The 2080 toothpaste recall in January 2026 then exposed weak supply-chain governance at exactly the wrong moment, and cost the seller KRW 22.5 bn in deal value.
Under Taekwang, management has chosen growth over margin. The early evidence is encouraging on the top line: record Q2 2026 revenue of KRW 194.2 bn, overseas share at 42%, a Walmart listing for Kerasys, and Olive Young USA for AGE20's and LUNA. The evidence on profitability is not yet encouraging. Operating margin is near zero on a trailing basis, inventory has risen to KRW 121.9 bn, and the only published model sees FY2026 operating profit of just KRW 7.4 bn.
The valuation reflects this ambivalence. The shares trade at about 0.7x book value and about 5x EV/EBITDA, with net cash covering about 40% of market value. That is a meaningful margin of safety for patient capital. The 50%-cosmetics-by-2028 target is credible only if signiq and ONE THING achieve US traction. That is unproven: the US is still about 5% of overseas sales, and the company spends roughly 0.5% of revenue on R&D in an increasingly innovation-driven category.
Our synthesis: neutral, with positive asymmetry from a low base. The downside appears cushioned by cash, book value and the household franchise. The upside requires evidence that marketing spend converts into durable, non-China revenue at margins comparable to Korean indie peers. The decisive data points are Q4 2026 sell-through and FY2027 margin direction. Legal and regulatory overhangs (MFDS, KFTC, humidifier litigation) are reputational more than financial for the company itself, but remain headline risks.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Background |
|---|---|---|---|
Kim Sang-jun (김상준) | CEO and inside director; sole CEO since March 2026 | CEO since 1 Dec 2023; reappointed at the March 2026 AGM | Former Executive Vice President (전무) at the company; described by the group as experienced across strategy, finance and general management. Age and education not disclosed in the sources reviewed. |
Chae Dong-seok (채동석) | Former co-CEO / Vice Chairman (owner family of Aekyung Group) | Stepped down at the March 2026 AGM | Second son of Aekyung Group Chair Jang Young-shin |
Jung In-chul (정인철) | Non-executive director (기타비상무이사) | Appointed at the March 2026 AGM | Executive VP and head of future business at Taekwang Industrial; recruited by Taekwang in 2025 to lead its Future Business Office |
Outside directors (3) | Independent directors | All three replaced in March 2026 | Professors of taxation, accounting and marketing. |
Major Shareholders
| Holder | Stake |
|---|---|
Taekwang Industrial + 2 (consortium SPC with T2 Private Equity and Yuanta Investment) | 63.15% |
— of which Taekwang Industrial's economic share | about 50% of the 16.67 m-share block (about 31.56% of the company) |
Treasury shares | about 4.6% |
Foreign investors (aggregate) | 1.59% (30 Sep 2026) |
Insiders / institutions (aggregator) | 0.30% / 0.46%; free float about 8.0 m shares |
Competitive Landscape
Peer Comparison FY2025
| Metric | Aekyung Industrial | Amorepacific Corp. | LG H&H | APR |
|---|---|---|---|---|
Revenue (KRW Bn, FY2025) | 654.5 | 4,250 (Group 4,620) | 6,355.5 | about 1,520 (implied from OP and margin; derived) |
Revenue growth FY2025 (%) | -3.6 | +9.5 | -6.7 | — |
Operating profit (KRW Bn) | 21.1 | 335.8 | 170.7 | 365.4 |
Operating margin (%) | 3.2 | 7.9 | 2.7 | 24 |
Beauty-segment note | Cosmetics OP 7.4 | Overseas revenue +15% | Beauty segment operating loss of 97.6 | High-growth device and skincare model |
R&D intensity | about 0.5% (expense line) | — | — | — |
Peer Comparison FY2025 (Annual)
| Company | Market cap (KRW Bn) | FY2025 revenue (KRW Bn) | FY2025 OP margin (%) | Valuation note |
|---|---|---|---|---|
Aekyung Industrial | 295.5 | 655 | 3.2 | Not rated; FY2025 P/E 22.8x; P/B 0.8x |
VT | 424.9 | 437 | 19.0 | 12-month forward P/E 6.5x |
Clio | 211.4 | 329 | 5.0 | P/E 5.8x |
Able C&C | 265.9 | 242 | 7.4 | 12-month forward P/E 8.5x |
I'm Family SC | 137.1 | 224 | 12.1 | 12-month forward P/E 6.5x |
Tonymoly | 119.9 | 220 | 6.5 | 12-month forward P/E 11.4x |



